Cargando…
An Open‐Label Dose‐Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients
Autores principales: | Rutherford, Elaine, Stewart, Graham, Houston, J. Graeme, Jardine, Alan G., Mark, Patrick B., Struthers, Allan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655768/ https://www.ncbi.nlm.nih.gov/pubmed/28597919 http://dx.doi.org/10.1002/jcph.939 |
Ejemplares similares
-
A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
por: Rutherford, Elaine, et al.
Publicado: (2020) -
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009) -
Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011) -
The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout
por: Baumgartner, Scott, et al.
Publicado: (2018) -
Allopurinol in Patients with Pulmonary Hypertension Associated with Chronic Lung Disease
por: Liu-Shiu-Cheong, Patrick S K, et al.
Publicado: (2020)